Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Web-delivered Provider Intervention for Tobacco Control (QUIT-PRIMO)

This study has been completed.
Sponsor:
Collaborators:
Johns Hopkins University
University of Alabama at Birmingham
Information provided by (Responsible Party):
Thomas Houston, University of Massachusetts, Worcester
ClinicalTrials.gov Identifier:
NCT00797628
First received: November 24, 2008
Last updated: August 27, 2013
Last verified: August 2013
  Purpose

This is a randomized control trial to determine the efficacy of a multi-modal intervention in improving smoking cessation processes of care and patient outcomes in community-based primary care practices. Our Overall Goal is to advance science related to the use and impact of the Internet in health services delivery, specifically smoking cessation, by targeting primary care clinical microsystems. A clinical microsystem is defined as the smallest functional healthcare unit. A clinical microsystem is not simply equivalent to a clinical team of doctors and nurses, but also the panel of patients cared for by the providers and the processes of care that are used.


Condition Intervention
Smoking Cessation
Behavioral: Decide2Quit
Behavioral: Smoking Coach

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Health Services Research
Official Title: QUIT-PRIMO: Web-Delivered Clinical Microsystem Intervention for Tobacco Control

Resource links provided by NLM:


Further study details as provided by University of Massachusetts, Worcester:

Primary Outcome Measures:
  • Physician performance on refering patients that smoke cigarettes to the web intervention [ Time Frame: pre-intervention, 6 months, 12 months and 24 months ] [ Designated as safety issue: No ]
  • Of the smokers who are referred to the web intervention, the number who go to the site [ Time Frame: preintervention, 6 months, 12 months, 24 months ] [ Designated as safety issue: No ]
  • Point prevalence smoking cessation [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Enrollment: 174
Study Start Date: March 2010
Study Completion Date: August 2013
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Information Prescription
Providers will give usual care to patients who smoke and a paper prescription with the name and url of the "Smoking Coach" website. The smoking coach website is a tailored, public health intervention for smoking cessation.
Behavioral: Smoking Coach
Control Patients will be referred by paper prescription to the control- "Smoking Coach" website.
Experimental: QUIT-PRIMO
Providers will give usual care to patients who smoke and then refer patients to the online smoking cessation system electronically.
Behavioral: Decide2Quit
Patient intervention website that includes 1) interactive calculators to assess readiness to quit, symptoms and quit plan, 2) motivational content, and 3) links to other high quality information.

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Community based primary care practices who have:

    • Internet access in office
    • Sees 4 - 5 smokers per week

Exclusion Criteria:

  • Practices with more than five providers
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00797628

Locations
United States, Massachusetts
University of Massachusetts Medical School
Worcester, Massachusetts, United States, 01655
Sponsors and Collaborators
University of Massachusetts, Worcester
Johns Hopkins University
University of Alabama at Birmingham
Investigators
Principal Investigator: Thomas K Houston, MD University of Massachusetts, Worcester
  More Information

No publications provided by University of Massachusetts, Worcester

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Thomas Houston, Principal Investigator, University of Massachusetts, Worcester
ClinicalTrials.gov Identifier: NCT00797628     History of Changes
Other Study ID Numbers: X071211009, NIH R01CA129091
Study First Received: November 24, 2008
Last Updated: August 27, 2013
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on November 23, 2014